The most important number on Enhance.MD’s website is not necessarily the largest price displayed. Its homepage advertises compounded semaglutide starting at $112 for the first month and $212 per month afterward, while the product page connects that $212 figure to a plan labeled “12-month” and billed every 48 weeks. For someone comparing household expenses, those are different pieces of information: an introductory advertisement, a monthly price presentation and a billing schedule. None should substitute for the actual amount due at checkout.
Enhance.MD documents a substantial telehealth offering rather than medication alone: intake, laboratory testing, clinician review, prescription fulfillment and continuing support. This review examines those services through their cost implications, using sources consulted October 19, 2026. The strongest feature is the specificity of many advertised inclusions. The main weakness is that the supplied public materials do not fully reconcile longer-plan billing with the general 28-day renewal language, or establish the complete financial consequences of leaving a longer plan.
At a glance
- Lowest advertised prices
- Core starts at $112 for the first month and $212/month afterward; Advanced at $180 and $280; Elite at $222 and $322. Their lowest ongoing figures correspond to plans labeled 12-month and billed every 48 weeks.
- Four-week options
- The plans labeled 1-month list Core at $249, Advanced at $329 and Elite at $379, billed every four weeks, with $50 off the first order advertised.
- Bundled services
- The main GLP-1 subscriptions advertise four weeks of medication, ongoing provider care, metabolic labs every six months, supplies, wellness coaching and educational platform access.
- Payment restrictions
- Services are cash-pay and not billable to Medicare or Medicaid. The FAQ accepts major credit cards but excludes gift, preloaded and FSA/HSA cards.
- Limited refund promise
- Core’s page promises a full initial-payment refund if onboarding determines the patient is ineligible for the formulation. This is not a general results guarantee or a documented prorated-refund policy.Sources: [5]
Start with the amount collected, not the monthly headline
Enhance.MD’s homepage presents three main tiers: Core, featuring semaglutide; Advanced, featuring tirzepatide; and Elite, combining semaglutide and tirzepatide. The headline first-month prices are starting-at offers, not standalone evidence of a freely cancelable monthly arrangement. Core’s $112 introductory figure appears beside $212/month; Advanced shows $180 followed by $280/month; Elite shows $222 followed by $322/month. The product pages associate those ongoing figures with their longest advertised billing interval.
The longer plans advertise $100 off the first order, alongside percentage discounts tied to plan length. The one-month options advertise $50 off the first order. Those terms explain more than a broad promotional reference to up to $150 off, which the supplied product blocks do not fully reconcile. Before paying, request a written breakdown separating the selected plan, promotional reduction, immediate charge and next charge. Our guide to understanding the first payment explains why these distinctions matter.
The supplied evidence does not specify the complete amount collected upfront for every longer plan. It also does not establish whether every displayed monthly amount is independently payable each month. Multiplying a headline figure into an assumed checkout total would therefore overstate what is documented. The useful comparison is the actual payment obligation offered to you, not a reconstructed total or an assumed annual savings figure.
| Program and presentation | Advertised monthly figures by plan label | Billing intervals and introductory conditions |
|---|---|---|
| Core: compounded semaglutide, subcutaneous injection | 12-month: $212; 6-month: $224; 3-month: $237; 1-month: $249 | Respectively every 48, 24, 12 or 4 weeks. Longer plans advertise 15%, 10% or 5% savings plus $100 off the first order; 1-month advertises $50 off. |
| Advanced: compounded tirzepatide, subcutaneous injection | 12-month: $280; 6-month: $296; 3-month: $313; 1-month: $329 | Respectively every 48, 24, 12 or 4 weeks. Longer plans advertise 15%, 10% or 5% savings plus $100 off the first order; 1-month advertises $50 off. |
| Elite: semaglutide plus tirzepatide, subcutaneous injection | 12-month: $322; 6-month: $341; 3-month: $360; 1-month: $379 | Respectively every 48, 24, 12 or 4 weeks. Longer plans advertise 15%, 10% or 5% savings plus $100 off the first order; 1-month advertises $50 off. |
| Tirzepatide microdosing program | 12-month: $169; 6-month: $179; 3-month: $189 | Respectively every 48, 24 or 12 weeks. A 1-month block says billing every 4 weeks but does not show an unambiguous price. |
The renewal calendar needs its own explanation
The plan labels use months, but the billing schedules use weeks. A plan labeled one month bills every four weeks; the three-, six- and 12-month labels correspond to 12, 24 and 48 weeks. These are not calendar-month intervals. They also do not, on their own, prove a minimum commitment or establish how much medication is supplied in a single shipment. The distinction is especially important when matching recurring charges to a monthly household budget.
A separate FAQ says membership automatically renews every 28 days. That matches the four-week option but leaves an unresolved question for the longer plans: does the 28-day language describe a service or refill cycle, or an additional financial renewal? The supplied documents do not settle that point. Ask Enhance.MD to identify the controlling schedule for the exact product and plan, including the next payment date. The billing-cycle guide offers a framework for recording that answer.
The provider’s “same price at every dose” guarantee is useful but narrower than a universal price lock. Enhance.MD says increasing the dose does not increase the flat rate. That does not erase the documented price differences between plan lengths, establish future promotional eligibility or explain a switch between Core, Advanced and Elite. A written quote should distinguish dose-related pricing from changes in the program, billing interval or renewal terms.
What the bundled price actually buys
The three main programs list a relatively broad service package. Core includes four weeks of semaglutide, continuing provider care, metabolic testing every six months, essential supplies, wellness coaching and educational platform access. Advanced lists the same categories for compounded tirzepatide and explicitly names syringes and alcohol pads. Elite describes four weeks of its semaglutide-and-tirzepatide formulation with the corresponding care, testing, supplies and educational services. These are provider-described inclusions, not independently tested service performance.
Core also advertises free shipping and medication delivery every four weeks. That describes the delivery cadence, not a guaranteed transit time or the quantity dispatched under every longer billing arrangement. The supplied materials do not establish a specific interval from clinical approval to dispatch or from dispatch to arrival. For budgeting, free shipping removes an advertised shipping charge; it does not answer when treatment starts or whether every later shipment follows the same schedule.
The private portal allows patients to review laboratory results and treatment and communicate with the care team. However, the exact frequency and format of follow-up consultations are not established in this sample. Before valuing “ongoing care” as a substitute for separately purchased visits, ask which encounters are included and how additional appointments are handled. Our explanation of what program prices include helps separate a named service category from a clearly defined entitlement.
Payment precedes the final prescribing decision
Enhance.MD describes the initial medical intake as free. It asks about lifestyle and medical history, but completing that form is not equivalent to receiving treatment. The FAQ says payment follows intake and precedes the virtual meeting, with medication delivered only if the patient is found eligible. The platform explicitly states that payment does not guarantee prescribing or dispensing. That makes the initial-payment refund conditions particularly important rather than a minor detail buried after enrollment.
The more detailed onboarding account includes baseline testing at a nearby Quest Diagnostics location. Advertised tests are a comprehensive metabolic panel, thyroid-stimulating hormone, lipids and hemoglobin A1c. The FAQ estimates that results reach Enhance.MD approximately one to two business days after the laboratory visit and appear in the account dashboard. It then describes an email prompting the patient to schedule a video consultation. That estimate concerns laboratory results, not medication shipment or arrival.
Some pages summarize enrollment in three steps without showing laboratory testing, while the fuller process includes it. Confirm the sequence for the selected program, especially when estimating how long a paid enrollment may take before prescribing. Identity verification is another prerequisite: the FAQ requires a full-face photograph and government-issued identification. An account can be created without completing verification, but Enhance.MD says healthcare services cannot be provided until that requirement is satisfied.
Pharmacy choice can change the bill
Enhance.MD’s FAQ names Tru Meds Rx, Strive Pharmacy and Pharmacy Hub as pharmacy partners. Its terms instead name Rite-Away Pharmacy, Vios Compounding Pharmacy and TruMedsRx, along with other licensed pharmacies. The lists overlap only partly, so neither should be treated as confirmation of which pharmacy will prepare or ship a particular prescription. The FAQ also requires a physical shipping address. Ask for the assigned pharmacy and its contact information before relying on a delivery arrangement.
A meaningful exception to the bundled-price presentation appears in the FAQ: a prescription can be sent to a pharmacy chosen by the patient, but medication costs are then billed directly to the patient. The documents do not explain a corresponding reduction in the program fee. Someone using this option should therefore obtain both the platform charge and the pharmacy price, rather than assuming the advertised medication inclusion follows the prescription into a different dispensing channel.
The legal division of responsibilities matters when resolving a charge or shipment problem. Enhance.MD LLC describes itself as an administrative and operational platform, not a provider of medical or pharmacy services. Its footer identifies Enhance Wellness PC and iThriveMD PC as clinical organizations; the terms additionally name EnhanceMD CA, PC. The FAQ says its clinicians are U.S.-licensed physicians and nurse practitioners. These are the provider’s representations, not independent credential or licensing verification.
Cancellation, refunds and payment restrictions
The terms say subscriptions renew automatically unless canceled before the next billing cycle, with complete subscription and payment terms supplied at checkout. The FAQ warns that pausing or canceling affects prescription refills. Neither statement establishes a refund for unused time or medication under a longer plan. The supplied record does not include the linked shipping-and-returns policy or final checkout terms, leaving prorated refunds, potential penalties and longer-plan exit obligations unresolved.
Core’s stated onboarding guarantee is more specific: if the patient is found ineligible for the formulation during onboarding, Enhance.MD promises 100% of the initial payment back. This is not a promise of weight-loss results or a general right to reverse later charges. The FAQ says refund processing usually takes five to ten business days; it does not guarantee bank receipt within that window. Review the distinction between canceling and receiving a refund before committing funds.
The service is cash-pay. Its terms exclude billing to federal or state healthcare programs, including Medicare and Medicaid, and place responsibility for costs on the patient. The FAQ accepts Visa, Mastercard, Discover and American Express, but not gift cards, preloaded cards or FSA/HSA cards. Private-insurance reimbursement procedures are not established in the supplied evidence. Card acceptance restrictions should not be converted into an unsupported conclusion about tax eligibility or benefits reimbursement.
Lower-priced and premium options need separate scrutiny
The tirzepatide microdosing program has its own economics. It advertises $169, $179 or $189 per month for plans labeled 12, six or three months, billed every 48, 24 or 12 weeks. Its one-month block lists four-week billing without an unambiguous price. Medication delivery is advertised every 12 weeks, unlike the main programs’ four-week cadence. The page also acknowledges that fewer side effects are not guaranteed. That acknowledgment should remain separate from any assumption that lower pricing establishes better value.
NAD+ is another distinct offering, advertised on the homepage starting at $169 per month for subcutaneous injections. The supplied pages also describe sublingual NAD+ wafers, with NAD+ blocks interspersed among GLP-1 content. Their presence does not establish that NAD+ is included in every GLP-1 subscription or that every nearby price applies to the selected GLP-1 product. Similarly, Elite’s premium positioning and combination formulation are marketing distinctions, not evidence that paying more produces a better individual outcome.
Core discloses that its compounded formulation is not FDA approved and says it is prepared under Section 503A guidelines for patients with demonstrated clinical need. FDA explains that compounded drugs do not undergo its premarket review for safety, effectiveness and quality, and recommends them when an individual’s needs cannot be met by an approved drug. Nonapproval alone does not establish clinical inequivalence. Nor do trials of specific medicines establish outcomes for Enhance.MD’s formulations, its combination or microdosing program.
Confirm availability and get an actionable quote
The terms limit access to adults 18 or older in locations where services are available. Although the FAQ claims licensing in all 50 states, its product-availability list is narrower: AK, AZ, CA, CO, CT, DC, DE, FL, IA, ID, IL, IN, KS, KY, MA, MD, ME, MI, MN, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SD, TX, UT, VA, VT, WA, WI, WV and WY. Confirm the selected product for your location.
The FAQ lists a minimum BMI of 25 for new GLP-1 patients and 20 for maintenance patients currently taking or recently having taken GLP-1 treatment. These are Enhance.MD’s advertised screening criteria, not individualized treatment advice; the provider also considers medical history. For financial preparation, ask support to document the exact first charge, renewal date, included services, assigned pharmacy and cancellation consequences. Published contacts are 1-888-299-5088 and support@enhance.md, with hours Monday–Friday, 8 a.m.–8 p.m. EDT, and weekends, 9 a.m.–5 p.m. EDT.
Questions & answers
Can I get Core for $212 on a four-week payment plan?
The documented four-week option lists $249, with $50 off the first order advertised. The $212/month figure belongs to the plan labeled 12-month and billed every 48 weeks. The public evidence does not establish the exact longer-plan checkout collection, so request that amount rather than treating $212 as an independently payable four-week rate.
Does Enhance.MD charge before a clinician decides whether to prescribe?
The FAQ describes payment after the free intake and before the virtual consultation. Payment does not guarantee a prescription or dispensing. Core’s onboarding guarantee promises a full initial-payment refund if the patient is found ineligible for its formulation. Confirm the applicable guarantee for the particular program before submitting payment.
Will using my own pharmacy keep medication inside the subscription price?
Not according to the documented alternative-pharmacy arrangement. The FAQ says a prescription can go to your chosen pharmacy, but that pharmacy bills you directly for medication. It does not document a matching reduction in Enhance.MD’s fee. Obtain both charges in writing before assuming the alternative costs the same as bundled fulfillment.
Can I cancel a longer plan and recover the unused balance?
The supplied documents do not establish that right. They require cancellation before the next billing cycle to prevent renewal and warn that cancellation affects refills. The initial-payment ineligibility guarantee is a separate provision. Ask for the longer plan’s refund, remaining-balance and cancellation rules at checkout; cancellation alone does not establish a refund.
Does the bundled laboratory testing mean results arrive with medication?
No. The FAQ’s approximate one-to-two-business-day estimate concerns receipt of laboratory results after the testing visit. It then describes scheduling a video consultation. The sample establishes no specific approval-to-dispatch or dispatch-to-arrival deadline. Ask for the expected sequence rather than treating the laboratory estimate as a medication delivery promise.
What if an injectable GLP-1 shipment arrives warm?
FDA explicitly recommends not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration, and contacting the provider or dispensing pharmacy. General shipping reassurance is not a substitute for resolving the condition of that shipment. Enhance.MD’s published support channels are 1-888-299-5088 and support@enhance.md; also obtain the dispensing pharmacy’s contact details.
Our assessment
Enhance.MD documents a broad cash-pay package with medication, recurring laboratory testing, supplies and continuing support, plus unusually detailed price tiers. Its dose-independent pricing promise and explicit onboarding-ineligibility refund are useful features. However, the lowest advertised monthly figures cannot be evaluated responsibly without the actual checkout charge, controlling renewal schedule and longer-plan exit terms. Pharmacy-list differences and undefined follow-up frequency add practical questions rather than proving poor service. The sensible next step is a written, product-specific quote that reconciles those points. Compare that obligation with the four-week option and confirm why the proposed compounded formulation fits the clinician’s assessment—not simply whether the introductory number looks affordable.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Enhance.MD — how it works ↗
- Enhance.MD — product/core semaglutide ↗
- Enhance.MD — official website ↗
- Enhance.MD — faq ↗
- Enhance.MD — product/advanced tirzepatide ↗
- Enhance.MD — terms of service ↗
- Enhance.MD — product/microdosing tirzepatide ↗
- Enhance.MD — product/elite tirzepatide and semaglutide ↗